InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,659.60
(
-2.28%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.19
(
0.09%
)
Bitcoin
56,967.19
(
-0.67%
)

Replies to post #60990 on Ayala Pharmaceuticals Inc (ADXS)

Replies to #60990 on Ayala Pharmaceuticals Inc (ADXS)
icon url

gold007_2000

03/27/18 4:05 PM

#60991 RE: gold007_2000 #60990

Barclays – Geoffrey Meacham (Overweight/$20)
Cantor Fitzgerald – Mara Goldstein (Overweight/$5)
Guggenheim Securities – Tony Butler, Ph.D. (Buy/$20)
H.C. Wainwright – RK Ramakanth, Ph.D. (Buy/$23)
Jefferies & Co. – Biren Amin (Buy/$9)
icon url

huskercatman123

03/27/18 4:09 PM

#60993 RE: gold007_2000 #60990

I think Catdog posted one time that pharma companies have different rules allegedly about reporting ownership. Not entirely sure?